Ardelyx, Inc. provided earnings guidance for full year 2023. For the year, the company expected net IBSRELA sales revenue for full year 2023 to be between $72 million and $77 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.855 USD | +1.11% | +1.56% | +10.56% |
05-24 | Ardelyx Shares Fall; Chief Commercial Officer Resigns | MT |
05-23 | Ardelyx, Inc. Announces Rodriguez Would Resign as Chief Commercial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.56% | 1.6B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ARDX Stock
- News Ardelyx, Inc.
- Ardelyx, Inc. Provides Earnings Guidance for Full Year 2023